Contemporary Clinical Trials Communications 8 (2017) 90–98
ContentslistsavailableatScienceDirect
Contemporary Clinical Trials Communications
journal homepage: www.elsevier.com/locate/conctc
ff
The e ect of a vegan versus AHA DiEt in coronary artery disease (EVADE
T
CAD) trial: Study design and rationale
Binita Shaha,b,∗ , Lisa Ganguzzaa, James Slatera, Jonathan D. Newmana, Nicole Allena,
Edward Fishera, John Larigakisa, Francisco Ujuetaa, Eugenia Gianosa, Yu Guoc, Kathleen Woolfd
aDepartmentofMedicine(Cardiology),NewYorkUniversity(NYU)SchoolofMedicine,NewYork,NY,USA
bDepartmentofMedicine(Cardiology),VeteransAffairsNewYorkHarborHealthcareSystem:ManhattanCampus,NewYork,NY,USA
cDepartmentofPopulationHealth(Biostatistics),NYUSchoolofMedicine,NewYork,NY,USA
dDepartmentofNutritionandFoodStudies,NYUSteinhardt,NewYork,NY,USA
A R T I C L E I N F O A B S T R A C T
Keywords: Background: Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when
Dietintervention comparedtonointerventionorusualdietarypatterns.Theaimofthisstudyistoevaluatetheeffectofavegan
Coronaryarterydisease diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic
Inflammation profilesinpatientswithangiographicallydefinedcoronaryarterydisease(CAD).
Glucose Studydesign: Thisstudyisarandomized,openlabel,blindedend-pointtrialof100patientswithCADasdefined
Lipids by≥50%diameterstenosisinacoronaryartery≥2mmindiameteroninvasiveangiography.Participantsare
randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017).
Participantsareprovidedweeklygroceriesthatadheretotheguidelinesoftheirdiet.Theprimaryendpointis
highsensitivityC-reactiveconcentrations.Secondaryendpointsincludeanthropometricdata,othermarkersof
inflammation,lipidparameters,glycemicmarkers,endothelialfunction,qualityoflifedata,andassessmentof
physicalactivity.Endpointsaremeasuredateachvisit(baseline,4weeks,and8weeks).Dietaryadherenceis
measuredbytwoweekly24-hdietaryrecalls,a4-dayfoodrecordduringtheweekpriortoeachvisit,andboth
plasmaandurinelevelsoftrimethylamine-N-oxideateachvisit.
Conclusion: Thisstudyisthefirsttocomprehensivelyassessmultipleindicesofinflammationandglucometa-
bolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-re-
commendeddiet.
1. Introduction elevated hs-CRP concentrations, highlighting the potential need for
alternativestrategiestoaddresstheresidualriskassociatedwithbase-
Inflammationplaysacentralroleinthedevelopmentandprogres- lineinflammationinpatientswithCAD[2].Addressingadversedietary
sionofatherosclerosis[1].Severalstudiessuggestanassociatedbenefit patternsmayallowpatientswithCADtopositivelyimpacttheiroverall
between a reduction in inflammation via statin or anti-inflammatory cardiovascular health. The American Heart Association (AHA) has
therapyandcardiovascularoutcomesinpatientswithcoronaryartery maintainedafocusona“hearthealthy”dietthatislowinsaturatedand
disease (CAD) [2–5]. The inflammatory state at the time of coronary transfatsandhighinfruitsandvegetablestoreducethehealthburden
revascularization also predicts clinical outcomes. High concentrations associated with cardiovascular disease and, as such, has been the re-
of C-reactive protein (CRP) at baseline, in particular, predict a sig- commended diet for patients with CAD. There is evidence to suggest
nificant increase in adverse cardiovascular outcomes after coronary that the lowering of low-density lipoprotein (LDL) cholesterol con-
revascularization [6–8]. In relatively healthy subjects with elevated centrationsisresponsiblefortheanti-inflammatoryeffectsnotedwith
concentrationsofhighsensitivity-CRP(hs-CRP)andnormallow-density statin medications [10]. Given the potential of lowering LDL-choles-
lipoprotein (LDL) cholesterol, initiation of statin therapy significantly terolconcentrationsfromthesubstitutionofanimal-basedproteinwith
lowers both hs-CRP concentrations and long-term major adverse car- plant-based protein, an antioxidant-rich vegan diet may improve the
diovascularevents[9]. inflammatory and glucometabolic state better than the AHA-re-
Approximately 30% of the treated stable CAD population has commendeddietinpatientswithCAD[11].
∗Correspondingauthor.423E23rdStreet,Office12023-W,NewYork,NY10010,USA.
E-mailaddress:binita.shah@nyumc.org(B.Shah).
http://dx.doi.org/10.1016/j.conctc.2017.09.003
Received11April2017;Receivedinrevisedform1September2017;Accepted13September2017
Available online 14 September 2017
2451-8654/ Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
Table1
InclusionandexclusioncriteriafortheEffectofaVeganversusAHADiEtinCoronaryArteryDisease(EVADECAD)trial.
Inclusioncriteria Exclusioncriteria
1.Angiographicallydefinedcoronaryarterydisease(definedas≥50% 1.Historyofaneatingdisorder
lesioninanarterywith≥2mmcaliber) 2.Onavegetarianorvegandiet
2.SpeakEnglishorSpanish 3.Useofsteroidsornon-steroidalanti-inflammatorymedicationsotherthanaspirinwithin5half-lives
3.Age≥18years ofbaselinevisitandduringthestudyperiod
4.Historyofamyocardialinfarctionorcoronaryarterybypassgraftsurgerywithinthepreceding3
months
5.Presenceofinfectionwithinthepreceding3months
6.Haveaplannedstagedcoronaryrevascularizationorothersurgicalprocedureduringstudyperiod
7.Historyofcoloncleansing(forstoolmicrobiomeanalysis)
8.Useofprobioticsoroverthecountersupplementsotherthanstandardvitamins(forstool
microbiomeanalysis)
9.Pregnant
10.Participatinginacompetingstudy
11.Haveanycondition(e.g.,psychiatricillness)orsituationthat,intheinvestigator'sopinion,may
confoundthestudyresults,ormayinterferesignificantlywiththepatient'sabilitytoadherewith
studyprocedures.
12.Scoreof>4toanyoftheamotivationalitemsoriftherelativeautonomyindex(definedas
averageofanswersforthe6autonomousitems–averageofanswersforthe6controlleditems)is≤0
ontheTreatmentSelf-RegulationQuestionnaire(Fig.1)
Althoughmultipledietaryfactorsinfluencecardiovasculardisease, Clinic (Cleveland, OH), measures markers of diet adherence (tri-
onlyafewstudiestodateexaminetheeffectsofoverallhealthydietary methylamine-N-oxide (TMAO), choline, and carnitine) in the plasma
patterns on cardiovascular disease risk [12–15]. Even fewer studies andurine.
compareaparticulardiettothestandardrecommendedhearthealthy ThePurjesFoundation(SaltLakeCity,UT)istheprimarysponsorof
diet in patients with cardiovascular disease, but, instead, utilize an thetrial.TheClevelandHeartLab,Inc(Cleveland,OH)measuresstan-
inappropriate control condition (no active intervention, usual dietary dard markers of inflammation (hs-CRP, myeloperoxidase, hemogram
patterns)asthecomparisongroup[15–18]. with differential), comprehensive lipid profiles, and glucometabolic
parameters at no cost. Itamar Medical Ltd (Caesarea, Israel) provides
2. Studyaims theEndoPatmachinetomeasureendothelialdysfunction.Thesponsors
didandwillnotcontributetothestudydesignordataanalysis.Thetrial
Theprimary aimofthis study isto determinetheimpactofan 8- isregisteredatclinicaltrials.gov(NCT02135939).
week vegan diet on inflammation, as measured by hs-CRP concentra-
tions, compared to the AHA-recommended diet in patients with an- 3.2. Timeline
giographically defined CAD. The secondary aims are to evaluate dif-
ferential effects of these two diets on other surrogate endpoints that Recruitment began at NYU Langone Medical Center on March 11,
may be affected by diet and impact clinical outcomes, including an- 2014andatBellevueHospitalCenteronNovember21,2014.Although
thropometric measures, other markers of inflammation, lipid para- therecruitmentperiodwasexpectedtotake2years,achievementofthe
meters, glycemic markers, endothelial function, quality of life, and targetstudy populationof100patientswithangiographically defined
physicalactivitypatternsinpatientswithCAD. CADwascompletedFebruary2,2017,11monthslaterthancompleted.
3. Methods 3.3. Eligibilitycriteria
3.1. Organizationalstructure The initial target study population was status post percutaneous
coronary intervention (PCI). However, due to a delay in recruitment,
This study is a randomized, open-label, blinded end-point trial of theinclusioncriteriawasamendedtoincludeanypatientwithangio-
patients with angiographically defined CAD at two campuses of the graphically definedCAD (≥50% lesion inan arterywith ≥2 mmca-
NewYorkUniversity(NYU)SchoolofMedicine,NYULangoneMedical
liber),whichwasapprovedonOctober8,2014.Specificinclusionand
CenterandBellevueHospital(NewYork,NY)[19].TheNYUSchoolof exclusioncriteriaaresummarizedinTable1.Participantshavetobeat
MedicineInstitutional ReviewBoard, whichapprovedthestudy,does least3monthspost-myocardialinfarction,coronaryarterybypassgraft
not require a Data Safety Monitoring Committee for this study given surgery,orinfectiontominimizeconfoundersoftheprimaryendpoint,
thatthepotentialrisksofparticipationinthisstudyareonlythoseas- hs-CRP concentration. Everyeffort ismade to include equitable num-
sociatedwithbloodcollectionandbreachofconfidentiality.Thestudy bersofeachsex,andtherearenoenrollmentrestrictionsbasedonrace
investigators, Binita Shah, MD, Jonathan Newman, MD, Kathleen and/orethnicorigin.However,giventhatthestudyteam,particularly
Woolf,PhD,RD,andJamesSlater,MD,overseeallstudyactivitiesand thestudyregistereddietitian,canonlyprovidedetailedcounselingin
implementation of the study design. Drs. Shah and Newman review English orSpanish, individuals whoprimarily speakalanguage other
data on a monthly basis to ensure the safe and proper treatment of thanEnglishorSpanisharenotrecruitedforthestudy.Thestudydoes
participantsanddeterminewhetherthereareanysubstantialdeviations notincludeanyvulnerablesubjects.
fromtheprotocol.
KathleenWoolf,PhD,RDdevelopedthedietaryguidelines,sample 3.4. Screening
2-week menus, and recipes were developed for both groups. Binita
Shah,MDdirectsbloodsamplescollection,processing,andanalysisfor All study team members have specific training in the informed
soluble adhesion molecules, as well as markers of neutrophil surface consent process. Potential participants who meet inclusion/exclusion
activation and monocyte subtypes by flow cytometry in the NYU criteriaareprovidedwithanoralandwrittendescriptionoftheproject
SmilowResearchBuilding.StanleyL.Hazen,MD,PhD,attheCleveland and are asked to demonstrate their understanding of each step by
91
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
Fig.1.Treatmentself-regulationquestionnaire.Questions1through6assessautonomousregulation;questions7through12assesscontrolledregulation;andquestions13through14
assessamotivation.Patientswereexcludediftheygiveananswerof>4toanyoftheamotivationalitemsoriftherelativeautonomyindex(definedasaverageofanswersforthefirst6
autonomousitems–averageofanswersforthesecond6controlleditems)is<0.
summarizingthestudyinformation. bysummarizingtheinformationprovided.
Potentialparticipantswhoexpressinterestinthestudycompletea Participantsthen undergo randomization to either avegan dietor
written screening consent that allows the study team to administer a the AHA-recommended diet (based on the AHA Therapeutic Lifestyle
Treatment Self-Regulation Questionnaire, a validated questionnaire Changes(TLC)Diet).Giventhatweightlossisnotaprimarygoalofthe
thatassessesthedegreetowhichone'smotivationforaparticularbe- study, participants are not given energy goals. Dietary recommenda-
haviorisrelativelyautonomousorself-determined(Fig.1)[20,21].The tions for both diets were developed using a 2000 kcal intake. The
items on the questionnaire relate to the reasons why an individual randomizationsequenceiscomputer-generatedbythestudybiostatis-
wouldmakehealthierchangestotheirdietorcontinuecurrenthabits. ticianusinga1to1allocation.Amemberofthecardiovascularclinical
Potentialparticipantsareexcludediftheygiveananswerof>4toany researchcenter,whoisnotamemberofthestudyteam,hasaccessto
oftheamotivationalitems(questions13and14)oriftherelativeau- thissequence andprovidesthedietary assignmentviaemail afterthe
tonomyindex(definedastheaverageofanswersforthefirst6auton- participant provides written consent. All laboratory technicians per-
omousitemsminustheaverageofanswersforthesecond6controlled formingtheendpointassaysareblindedtorandomizationgroup.
items) is < 0 (Fig. 1) [20,21]. Participants who meet the inclusion Onceadietisassigned,thestudy registereddietitiancounselsthe
criteria based on the Treatment Self-Regulation Questionnaire are participantontheassigneddiet(Supplementalappendix1),providing
provideda4-dayfoodrecordandinstructionsonhowtofilloutthese extensive nutrition education and resources. . Study participants are
food records during the week prior to their scheduled baseline visit given measuring cups, measuring spoons, a food scale, a cookbook,
(Fig.2). handoutsfromtheNutritionCareManual®oftheAcademyofNutrition
and Dietetics (www.eatright.org) (12 pages), a 2-week sample menu
with recipes (Supplemental appendix 2), and a large magnet for the
3.5. Baselinevisitandrandomization participant's refrigerator with summary dietary guidelines. Nutrient
analyses for the 2-week sample menus were completed using Food
Participantswhofillouttheir4-dayfoodrecordare,again,provided
Processor 11.0.137 (ESHA research, Salem, OR). The 2-week sample
anoraldescriptionoftheprojectandgivewritteninformedconsentto menusforbothdietsweredevelopedusinga2000-kcalguidelinewith
participateinthetrialatthebaselinevisit.Onlystudyteammembers 15%caloriesfromprotein,60%fromcarbohydrates,and25%fromfat.
withspecifictrainingintheinformedconsentprocessobtainthiscon-
TheveganandAHAdietgroupsaregiventhecookbooksSimplyVegan
sent,andparticipantsarerequiredtodemonstratetheirunderstanding
92
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
Fig.2.Four-dayfoodrecord.
(Baltimore: Vegetarian Resource Group, 2012) and American Heart Model WW24WN, East Windson, NJ, USA), and waist circumference
Association Low-Fat, Low-Cholesterol Cookbook (New York: Clarkson (Mabis tape measure, Model 35-780-000, Waukegan, IL, USA). Waist
Potter,2008),respectively.KathleenWoolf,PhD,RDtestedallrecipes circumferenceismeasuredattheleveloftheiliaccrestwhilethepar-
providedinthe2-weeksamplemenupriortoimplementation.Ofnote, ticipantisinthestandingposition,andanaverageoftwomeasuresare
all participants are encouraged and expected to continue to take any recorded. An average of three blood pressure measurements taken
medicationhisorherphysicianhasprescribed. 1minapartarerecordedwhiletheparticipantisinthesittingposition
[22].Pertinentmedicalhistoryisobtainedfromparticipantinterview
3.6. Dietaryfollow-up andreviewoftheelectronicmedicalrecord.Tobaccouseisdefinedas
useof>100cigarettesor5pipesinalifetime,andcurrenttobaccouse
Participants are provided $80 worth of groceries per week from a is defined as use within the past 6 months. Baseline medications are
fooddeliverycompanythatservicestheirarea.Participantssupplement definedasthoseusedforatleast7dayspriortothebaselinevisit.Left
the $80 per week with their own purchases and are counseled to eat ventricular ejection fraction is categorized as normal or borderline
within the recommendations of their assigned diet with food choices (≥50%), mildly or moderately reduced (35%–49%), or severely re-
andpurchasesoutsideofgroceryitems.Thestudyregistereddietitian duced (<35%) and collected from review of noninvasive data oran-
callsthepatienttwiceweeklyonrandomdaysthroughoutthe8weeks giography, whichever modality was performed for clinical reasons
of the study to answer questions, obtain 24-h dietary recalls (twice a closest to the time of baseline visit. Finally, a physician investigator
week),andobtainfoodrequestsfromtheparticipantforagroceryorder determinestheindicationforcoronaryangiographyanddegreeofCAD
specifically designed for this study (once a week) (Supplemental ap- basedonreviewoftheinvasivecoronaryangiographyreport(Table2).
pendices3and4). At the 4-week interim and 8-week final visits, trained study per-
Twofollow-upin-personvisitsarescheduled—oneat4weeksand sonnel again measure height, weight, waist circumference, and blood
oneat8weeks(interimandfinalvisits,respectively).Participantsare pressureperprotocol,andparticipantsareaskedaboutcurrentsmoking
instructedtofillouta4-dayfoodrecordduringtheoneweekpriorto statusandchangesinmedicationsfromthepriorvisit.
eachfollow-upvisit.
Long-termfollow-upisassessedbyatelephonecallat3months,6 3.8. Endpointsofinterest
months, and yearly for up to 5 years. At each time point, details on
interim clinical events (stress test, coronary angiography and/or re- For each visit (baseline, 4-week interim, and 8-week final), parti-
vascularization,myocardialinfarction,developmentorhospitalization cipantsareinstructedto1)drinkplentyoffluidsonthedaybeforetheir
forcongestiveheartfailure,strokeortransientischemicattack,cardiac appointment;2)notconsumeanyfoodaftermidnightthenightbefore
arrest,death)areobtainedandanother24-hdietaryrecalliscompleted. the visit (water is allowed); and 3) wear loose-fitting, comfortable
Participants are also asked questions: 1) Are you still following the clothing. Blood is collected using standard peripheral venipuncture
assigneddiet?(Ifnot,areyoufollowinganyspecificdiet);2)Howdo techniqueswitha21-guageneedle.Upto45ccofbloodiscollectedin
youratethehealthfulnessofyouoveralldiet?(nothealthy,somewhat the following order: 3.2% (0.109 mol L−1) sodium citrate tubes (BD
healthy,healthy,veryhealthy,extremelyhealthy);and3)Whatisyou Vacutainer, Franklin Lakes, New Jersey), serum separator tubes (BD
currentweight? Vacutainer, Franklin Lakes, New Jersey), 5.4-mg K2 EDTA tubes (BD
Vacutainer,FranklinLakes,NewJersey),andaZserumseparatorclot
3.7. Covariatesofinterest activatorlipotube(GreinerBio-One,Monroe,NorthCarolina).Citrate-
and EDTA-anticoagulated bloods designated for plasma collection are
Demographicandsocioeconomicinformationareself-reported,and centrifugedwithin15minofcollectionat2500gfor10min.Bloodin
trainedstudypersonnelmeasurevitalsigns,includingheight(Seca216, the serum separator tubes and the lipotube are allowed to clot for
Model 1814009, Chino, CA, USA), weight (Conair Weight Watchers, 30minatroomtemperaturepriortocentrifugationat2500gfor10min.
93
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
Table2
CovariatesofinterestintheEffectofaVeganversusAHADiEtinCoronaryArteryDisease(EVADECAD)trial.
BaselineCharacteristics BaselineCharacteristics(continued)
1.Demographicdata 5.Smokinghistory
a.Age a.Useof>100cigarettesor5pipesinlifetime
b.Sex b.Usewithin6months(currentvsformer)
c.Race 6.Baselinemedications(foratleastthe7dayspriorvisit)
d.Ethnicity(Hispanicornon-Hispanic) 7.Leftventricularejectionfraction
2.Socioeconomicdata 8.Indicationforcoronaryangiography
a.Highestlevelofeducation 9.Numberofcoronaryarteriesdiseased(≥50%diameterstenosisinanarterywith≥2mmcaliber;or
b.Totalhouseholdincome physiologicallysignificantbyfractionalflowreserve;orpreviouslyrevascularized)
c.Employmentstatus
d.Maritalstatus 4-WeekInterimand8-WeekFinalVisits
e.Homezipcode
3.Vitalsigns 1.Height,weight,andwaistcircumference
a.Height 2.Smokingstatus
b.Weight 3.Changesinmedicationsfrombaselineandinterimuseofantibiotics
c.Waistcircumference 4.Interimevents
d.Heartrate a.Emergencyroomvisitwithorwithoutobservationorinpatientadmission
e.Bloodpressure(sittingposition;averageof3measures) b.Heartattack(detailsofcardiacbiomarkerscollectedifansweredaffirmatively)
4.Pertinentmedicalhistory c.Strokeormini-stroke
a.Hypertension d.Hospitalizationforheartfailure
b.Hyperlipidemia e.Resuscitatedcardiacarrest
c.Myocardialinfarction f.Cardiacprocedure(includingcoronaryangiographyand/orcoronaryrevascularization)
d.Percutaneouscoronaryintervention g.Outpatientclinicvisits
e.Coronaryarterybypassgraft h.Cardiacrehabilitationvisits
f.Congestiveheartfailurerequiringtreatment i.Death
g.Diabetesmellitus
h.Peripheralarterydisease Long-TermFollow-UpCalls
(known≥50%ormoderateorseverestenosis;historyof
revascularization) 1.Patient-reportedweight
i.Carotidarterydisease 2.Changesincardiacmedicationsfromlastcontact
(known≥50%ormoderateorseverestenosis;orhistoryof 3.Interimevents(sameasabove)
revascularization)
j.Cerebrovasculardisease
(clinicalhistoryofTIAorstroke)
k.Abdominalaneurysm
l.Chronicrenaldysfunction(creatinine>1.5mg/dL)
m.Inflammatorycondition
n.Malignancy
Plasma and serum aliquots are stored at −80 °C until analysis. Good characteristic forward-side light scatter properties. All antibodies are
clinical practices are followed to certify proper storage and daily and directlyconjugatedandIgGantibodiesareusedascontrolsforallflow
long-term quality control of reagents, instruments, and technique. cytometry analyses. All other inflammatory markers (such as soluble
EndpointsareshowninTable3. selectinandintegrinmolecules)willbemeasuredintriplicateonstored
plasmaattheendofthestudyusingcommerciallyavailablemultiplex
assays.
3.9. Primaryendpoint
Lipid profiles are measured using nuclear magnetic resonance
spectroscopy. The lipid profiles include measures of total cholesterol;
The primaryendpoint ishs-CRP concentration. Serum samplesfor
LDL cholesterol (calculated); high-density lipoprotein (HDL) choles-
hs-CRP are shipped on the same day of collection at 2 °C–8 °C to the
terol; triglycerides; LDL, small LDL, and HDL particle numbers; large
ClevelandHeartLab,Inc(Cleveland,OH)foranalysis.
very low-density lipoprotein (VLDL) and large HDL; LDL, VLDL, and
HDLsize;andlipoproteininsulinresistanceindex.
3.10. Secondaryendpoints Glycemicmarkers,suchasbloodglucoseandinsulin,aremeasured
from serum, while hemoglobin A1c is measured from EDTA whole
Secondaryendpointsincludeanthropometricmeasures,othermar- blood.
kersofinflammation,lipidparameters,glycemicmarkers,endothelial Endothelium-mediatedchangesinvasculartonearemeasuredusing
function,qualityoflife,andphysicalactivitypatterns. the EndoPat device. Biosensors are placed on fingertips, and en-
MyeloperoxidaseismeasuredfromEDTAplasma,andwhiteblood dothelium-mediated changes in arterial tone are elicited by a down-
cell count with differential is measured from EDTA whole blood. stream hyperemic response induced by a standard 5-min occlusion of
Surface markers of neutrophil activity (L-selectin and CD11b) and thebrachialartery.Measurementsfromthecontralateralarmareused
monocytesubtypesaremeasuredusingcitrate-anticoagulatedbloodvia to control for concurrent non-endothelial dependent changes in vas-
anAccuriC6flowcytometer(BDBiosciences,FranklinLakes,NJ).For culartone,andtheratioofthetwomeasurementsresultinanindexof
neutrophil analyses, whole blood is stained with anti-L-selectin endothelialfunction.Anindexscoreof<1.67isconsideredabnormal
(CD62L) and anti-β integrin (CD11b) antibodies (BD Biosciences, [23].
2
FranklinLakes,NJ)within15minofcollection.Theneutrophilpopu- QualityoflifeisassessedusingtheEuroQolfivedimensionsques-
lation is identified by their characteristic forward-sidelight scatter tionnaire, which is comprised of a health state description and an
characteristics. To assess monocyte subtypes, formaldehyde-fixed evaluationcomponent.Onthequestionnaire,healthstatusisevaluated
whole blood is stained with CD86, CD14, and CD16 (BD Biosciences, infiveareas(mobility,self-care,usualactivities,pain/discomfort,and
Franklin Lakes, NJ). Monocytes are identified as CD86+ and have
94
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
Table3 asked about interim clinical events (emergency room visit, hospital
EndpointsofinterestintheEffectofaVeganversusAHADiEtinCoronaryArteryDisease observation or inpatient stay, admission to an extended care facility,
(EVADECAD)trial. cardiac rehabilitation, stress test, coronary angiography and/or re-
vascularization,myocardialinfarction,developmentorhospitalization
PrimaryEndpoint
HighsensitivityC-reactiveprotein forcongestiveheartfailure,strokeortransientischemicattack,cardiac
SecondaryEndpoints arrest, death). If a clinical event does occur outside the NYU system,
Anthropometricdata participantsareaskedforauthorization toobtaindetailsofthisevent
Weight
from the outside physician or facility if their NYU physician did not
Bodymassindex
already do so. Information regarding interim clinical events is also
Waistcircumference
Waistcircumferencetoheightratio capturedonlong-termtelephonefollow-ups.
Othermarkersofinflammation AllsecondaryendpointsaremeasuredatNYUSchoolofMedicine,
Myeloperoxidase with the exception of myeloperoxidase, white blood cell count with
Whitebloodcellcount differential,lipidprofiles,andglycemicmarkers,whichareshippedon
Neutrophil/lymphocyteratio
Neutrophil-surfaceexpressionofL-selectinandtheβ 2integrinCD11b thesamedayofcollectionat2°C–8°CtotheClevelandHeartLab,Inc
SolubleL-selectinandE-selectin (Cleveland,OH)foranalysis.
Solubleintercellularadhesionmoleculeandvascularcelladhesionprotein
Solubleneutrophilgelatinase-associatedlipocalin
3.11. Measuresofdietaryadherence
Monocytesubtypes
OxidizedLDL
UrineF2-isoprostane/creatinine Wedevelopedanovelassessmenttooltoevaluateadherencetothe
Lipidparameters animal protein recommendations for each diet. Adherence is assessed
Totalcholesterol eachweekusingtheinformationcollectedduringthetwo24-hdietary
Low-densitylipoprotein(LDL)cholesterol(calculated)
recalls. Participants on the vegan diet receive 1 point for abstinence
Directhigh-densitylipoprotein(HDL)cholesterol
Triglycerides fromeachofthefollowing:1)meat/poultry/eggs,2)dairy,3)seafood.
Non-HDLcholesterol Ascoreof≥5of6isconsideredadherentforthatweek.Participantson
LDL,smallLDL,andHDLparticlenumbers theAHAdietreceive1pointforconsumptionofeachofthefollowing:
Largeverylow-densitylipoprotein(VLDL)andlargeHDL 1)≤5ozofanimalprotein/day,2)onlylow-fat/fat-freedairy,3)fish
LDL,VLDL,andHDLsize
≥2 times/week. A score of ≥4 of 5 is considered adherent for that
Lp-PLA2
Lipoproteininsulinresistanceindex week.Participantsaredeterminedtobeadherentatthe4-weekinterim
Glycemicmarkers and 8-week final follow-ups if they are adherent for ≥2 of 3 weeks
Fastingbloodglucose evaluatedbetweenvisits.Asasecondarymeasureofdietaryadherence,
Bloodinsulin
MyPlateservingsoffruits,vegetables,andwholegrainsintakewillbe
HemoglobinA1c
Other assessedineachdietgroup.
Indexofendothelialfunction(EndoPAT,ItamarMedicalLtd,Caesarea, Participantsaretoldthatadherencetotheirassigneddietwillalso
Israel) bemeasuredviabloodandurine,butnofurtherdetailsareprovided.
Qualityoflife(EuroQol5dimensionsquestionnaire,healthevaluationona
Both plasma and spot urine trimethylamine-N-oxide (TMAO) con-
visualanaloguescale)
centrations, an oxidized metabolite of choline, are measured in all
PhysicalActivity(InternationalPhysicalActivityquestionnaire)
Clinicaloutcomes
participantsfromaliquotsstoredat−80°C.L-carnitineisanabundant
Majoradversecardiovascularevents(MACE)(acompositeofall-cause nutrient in red meat and contains a structure similar to choline [26].
mortality,non-fatal Thesemarkerswillbeusedasobjectiveevidenceofadherence.
myocardialinfarction,non-fatalstroke,andrepeatcoronary
revascularization)
IndividualcomponentsofMACE 3.12. Datastorageandconfidentiality
Allparticipantstudydataarekeptstrictlyconfidentialandmanaged
anxiety/depression),andeachareaisratedonathree-levelscale(1-no electronically with REDCap, a secure web-based application for
problems; 2-having some problems; 3-having extreme problems). The building and managing online databases [27]. The program provides
self-reported data are then summarized using the United States pre- automatedexportofdatatocommonstatisticalpackages(e.g.SPSS,R),
ference-weightedindexscore[24].Healthevaluationisassessedusing andbranchinglogic,fileuploading,andcalculatedfields.Hardcopies
avisualanaloguescale,a20cmverticalscalethatrangesfrom0to100 ofdataaresecuredinalockedcabinetinalockedofficeonNYUSchool
(“worst”to“bestimaginablehealthstate”),andreflectstheparticipant's
ofMedicineproperty.Allbiologicalspecimensareencodedwithastudy
overallhealthonthedayofthevisit. numberthathadnopatientidentifierinformation.
PhysicalactivityisassessedusingtheInternationalPhysicalActivity Food Processor 11.0.137 (ESHA research, Salem, OR) is used to
Questionnaire – short form (IPAQ-SF) [25]. Participants complete the enterthe24-hdietaryrecallsandfoodrecordsforeachparticipant.De-
questionnaireatthebaseline,4-weekinterim,and8-weekfinalvisits. identified dietary intake data are obtained for24 days as per the fol-
Briefly,theIPAQ-SFisashort,well-validatedinstrumentusedtoassess
lowingschedule:4-dayfoodrecordfromtheweekpriortothebaseline
atypicalweekofphysicalactivity[25].TheIPAQ-SFasksparticipants visitandatweeks4and8;andtwiceaweek24-hdietaryrecallsduring
toreportfrequency(daysperweek)andtimespentengaginginactiv- weeks 1 through 3 and weeks 5 through 7. The nutrient variables of
itiesthathavebeenperformedforatleast10mininthepast7daysat interest include: energy (kcal), protein (g), carbohydrates (g), dietary
three different levels of intensity (“walking”, “moderate”, and “vig- fiber(g),solublefiber(g),fat(g),saturatedfat(g),transfattyacids(g),
orous”). Examples for each intensity level are provided and include cholesterol(mg),omega3fattyacids(g),sodium(mg),andproportion
leisure,work,household,andtransport-relatedactivities.Thephysical ofrecommendationsmetforMyPlate.govfoodgroups(grain,vegetable,
activitydataarescoredfollowingestablishedmethodsandreportedas fruit,dairy,protein).
acontinuousmeasureinthemetabolicequivalentoftask-minutesper
week. 3.13. Statisticalanalysis
Finally,rateofmajoradversecardiovascularevents(acompositeof
all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, Demographic and baseline characteristics will be presented.
and repeat coronary revascularization) are assessed. Participants are Summary statistics (number, mean, standard deviation, median,
95
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
interquartile range) will be calculated for continuous variables. thesameresources:provisionofastarterkitthatincludesafoodscale,
Frequencyandpercentageswillbecalculatedforcategoricalvariables. measuringcups,measuringspoons,cookbook,two-weeksamplemenu
Normalassumptionswillbecheckedusingquantile-quantileplotsand with recipes, nutrition education materials summarizing the diet (12
Shapiro-Wilks test. Non-parametric alternatives and transformations pages),andhandoutsonservingsizeandinstructionsonhowtoread
willbeconsidered. nutrition labels, as well as weekly groceries. The only difference in
Baselinevariableswillbecomparedbetweenthetwodietarygroups theseresourcesisthesubstitutionofanimal-basedproteinintheAHA
with t-test for normally distributed continuous variables, Mann- groupforplant-basedproteininthevegangroup.
Whitney-Wilcoxon for skewed continuous variables, and tests of pro- Second, we provide groceries and dietary counseling for all study
portions for categorical variables. Changes in endpoints over time participants.Participantsinthisstudyreceive$80inweeklygroceries
withinandbetweengroupswillbecomparedusingalinearmixedeffect aspartofthestudydesign.Duringaweeklyphonecallfromthestudy
modeltoassesstheoutcomeovercovariatesincludingcollectiontime dietitian, participants complete a grocery order for food items to be
point(baseline,4-weekinterim,and8-weekfinal),typeofdiet,andthe deliveredtotheirhomefromagrocerydeliveryservice.Participantsare
interactiontermbetweenthesetwovariables.Theinteractiontermwill abletoselectitemsfromalistoffoods/ingredients(Supplementalap-
assess whether the changes in outcome over time differ between pendix4)thatsupportthedietaryrecommendationsoftheirinterven-
treatmentgroups.Althoughtheanticipatedrateofmissingdataisan- tionassignment.Participantsarealsoprovidedwithatwo-weeksample
ticipated to be low, appropriate statistical methods (e.g. last observa- menu that incorporates the foods/ingredients on the grocery order
tion forward, multiple imputation) will be used based upon the re- (Supplemental appendix 2). Most nutrition clinical studies utilize nu-
commendations ofthestudybiostatistician.Statistical significancefor trition education, cooking classes, educational resources, and in-
theprimaryendpointwillbetestedusinga2-sidedalphalevelof0.05. dividual/groupcounselingaspartofthestudydesignwheneducating
Theprimaryanalysiswillbeconductedasintention-to-treat.Secondary research participants on their respective intervention assignment.
analyses will include a per-protocol evaluation and a sensitivity ana- However, providing whole foods/ingredients to research participants
lysiswillbeconductedfordifferentthresholdsofadherenceasdefined mayenhanceadherencetothedietaryguidelinesandisaninnovative
bytheadherencetoolandmetabolites. aspectofthisstudy.Duringthe15one-on-oneeducationalsessionswith
thestudyresearchdietitian,theresearchparticipantslearnhowtoin-
3.14. Samplesizecalculation corporatethesefoods/ingredientsintohealthymeals,whichmaycon-
tinueoncethestudyhasended.Otherstudieshaveprovidedsomefood
Preliminary data from our cardiac catheterization laboratory de- items to research participants, such as meal replacement products,
monstratedameanhs-CRPconcentrationof2.07mg/L±0.57mg/Lin frozenfoodentrees,andmargarine[32,33].However,increasingdata
patients with CAD. Based on an estimated decrease in mean hs-CRP suggestafailureoftranslatingresearchfindingsintoclinicalpractice,
concentrationby20%withthevegandietascomparedtotheAHAdiet, particularly those related to adherence to dietary advice [34]. Our
anda2-sided2samplet-test,thenumberofparticipantsneededineach study provides study participants with the education and tools neces-
group to achieve 80% power at the 0.05 significance level was esti- sarytopreparehealthymealsthatfollowthedietaryrecommendations
matedtobe30[16].Weapproximatedthatupto40%ofthepartici- of their intervention assignment and sustain the behavior. This, to-
pantsenrolled mayhavelowhs-CRPconcentrationsatbaseline(floor getherwiththetwiceaweektelephonecallsfromthestudyregistered
effect)ordropout,and,thus,increasedthesamplesizeineachgroupto dietitian,maybeneficiallyimpactdietaryadherence[35].
50. Finally, approximately 1/3 of participants who signed screening Third, this study incorporates detailed scripts and guidelines, al-
consent were expected to not show up to their baseline visit prior to lowingtheinterventionmaterialstobedisseminatedconsistentlybythe
randomization.Therefore,IRBapprovalwasgrantedfortheconsentof study registered dietitian. A counseling guide was developed to en-
150 screened participants to reach ourgoal of 100 randomized parti- courageasimilardiscussionbetweenthestudyregistereddietitianand
cipants. study participants randomly assigned to each intervention group.
Furthermore,ascriptwascreatedforthe24-hdietaryrecallssothatthe
4. Discussion initiation of the conversation, questions asked, and guidance for par-
ticipantsweresimilarforparticipantsassignedtothesameintervention
PatientswithCADrequireevidenced-basedstrategiestoreducein- group.
flammationandimproveclinicaloutcomes.Lifestyleinterventions,in- Fourth, the multiple measures of adherence are another central
cludingdiet,maybeanimportantapproachtoaddresstherisksasso- aspect of the study's design. These measures include dietary intake
ciatedwithinflammation andimpactcardiovascular health.Although (animal protein recommendation for each diet; MyPlate servings of
epidemiological research supports the relationship between “heart fruits,vegetables,andwholegrains)andbothplasmaandurineTMAO
healthy” dietary patterns and vegan diets on inflammatory markers, concentrations.AlthoughTMAOconcentrationsareonlydetectedafter
well-designedrandomizedclinicaltrialsarelimitedandtheresultsare theconsumptionofredmeat,participantswereonlytoldthattherewas
mixed [28–31]. Furthermore, the study participants included in pre- amarkerinthebloodandurinethatallowedinvestigatorstodetermine
vious research may have been free from cardiovascular disease. We dietaryadherence[26].Auniquestudy-specificscoringsystemwasalso
presentthefirststudytodatetocomprehensivelyassesstheimpactofa developed,asdescribedabove,toquantitatelevelofdietaryadherence
vegan diet compared to the currently recommended AHA diet on usingsimilarcriteriaineachgroup.
multiple indices of inflammation and glycometabolic risk in a rando- Thereareseverallimitationstothecurrentstudy.First,theuseofa
mizedclinicaltrialofpatientswithangiographicallydefinedCAD. Treatment Self-Regulation Questionnaire maylimit generalizability of
Our study design incorporates several unique and innovative ele- the study results. Given our relatively small sample size, we need to
mentstoaddresstheresearchquestions.First,thisstudycomparesthe effectively enroll potentially adherent participants, allowing us to
impact of a vegan diet and the AHA diet on multiple indices of in- better examine the impact of the intervention. Second, although the
flammation and glycometabolic risk. All participants receive random studyregistereddietitianconsistentlyencouragesintakeofwholefood
assignment to an intervention with the potential to improve health. choicesateachofthe15educationalone-on-onesessions,convenience
Thus,thestudydesigncallsforasmuchattentiontothecontrolgroup itemsareallowedtopromoteadherencetothedietsinthereal-world
(AHA) as the comparator group (vegan). Participants are counseled setting.Third,thestudynutritioneducationmaterialsarebasedonthe
equally on their respective dietary guidelines and complete twice TLC Program, guidelines that were recommended by the AHA at the
weekly24-hdietaryrecallsthatallowforequalamountofcontactwith time the intervention materials were developed. Although dietary re-
theresearchdietitian.Theinterventiongroupsarealsoprovidedwith commendationscontinuetoevolve,theTLCProgramisconsistentwith
96
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
thecurrentAHAguidelines. complicationsandlaterestenosisaftercoronaryangioplasty,J.Am.Coll.Cardiol.
Finally, irrespective of the primary findings, this randomized
34(1999)1512–1521.
[8] D.H.Walter,S.Fichtlscherer,M.Sellwig,W.Auch-Schwelk,V.Schachinger,
blinded-endpoint trial will be of scientific importance as a large re- A.M.Zeiher,PreproceduralC-reactiveproteinandcardiovasculareventsafter
pository of biological specimens with a comprehensive analysis ofin- coronarystentimplantation,J.Am.Coll.Cardiol.37(2001)839–846.
flammatory markers, lipid profiles, and glucometabolic parameters in [9] P.M.Ridker,E.Danielson,F.A.Fonseca,J.Genest,A.M.GottoJr.,J.J.Kastelein,
W.Koenig,P.Libby,A.J.Lorenzatti,J.G.MacFadyen,B.G.Nordestgaard,
conjunction with detailed dietary reports in patients with CAD. Thus, J.Shepherd,J.T.Willerson,R.J.Glynn,JUPITERStudyGroup.Rosuvastatinto
the biologic repository can allow for exploration of the effects of dif- preventvasculareventsinmenandwomenwithelevatedC-reactiveprotein,N.
ferent dietary strategies on additional markers of cardiometabolic
Engl.J.Med.359(2008)2195–2207.
[10] A.Oesterle,U.Laufs,J.K.Liao,Pleiotropiceffectsofstatinsonthecardiovascular
health. In addition, the results of this study may provide preliminary system,Circ.Res.120(2017)229–243.
data for a larger randomized trial evaluating the effects of the two [11] xxx.
dietary strategies on traditional clinical cardiovascular outcomes in [12] L.J.Appel,T.J.Moore,E.Obarzanek,W.M.Vollmer,L.P.Svetkey,F.M.Sacks,
patients with CAD. Alternatively, if significant reductions in in- G tr. iA al. oB fra ty h, eT e. ffM e. cV tsog ot f, dJ i. eA t. aC ryut ple ar tt, eM rn.M so. nW bin lod oh dau ps re er s, sP u. rH e.. DLi An S, HN. CK oa lr laa bn oja r, aA tivc elinical
flammatory orglucometabolic profiles arenoted in both groups, data ResearchGroup,N.Engl.J.Med.336(1997)1117–1124.
from the current study may be used to support the evaluation of a [13] L.J.Appel,F.M.Sacks,V.J.Carey,E.Obarzanek,J.F.Swain,E.R.Miller3rd,
P.R.Conlin,T.P.Erlinger,B.A.Rosner,N.M.Laranjo,J.Charleston,P.McCarron,
rigorous approach to dietary counseling on long-term cardiovascular L.M.Bishop,OmniHeartCollaborativeResearchGroup.Effectsofprotein,mono-
eventsinpatientswithestablishedCAD. unsaturatedfat,andcarbohydrateintakeonbloodpressureandserumlipids:results
In summary, the EVADE CAD study is a unique and innovative oftheOmniHeartrandomizedtrial,JAMA294(2005)2455–2464.
randomized clinical trial comparing the effectiveness of an 8-week [14] B.V.Howard,L.VanHorn,J.Hsia,J.E.Manson,M.L.Stefanick,S.Wassertheil-
Smoller,L.H.Kuller,A.Z.LaCroix,R.D.Langer,N.L.Lasser,C.E.Lewis,
vegandiettotheAHA-recommendeddietonhs-CRPconcentrationsin M.C.Limacher,K.L.Margolis,W.J.Mysiw,J.K.Ockene,L.M.Parker,M.G.Perri,
patients with angiographically defined CAD. The study results may L.Phillips,R.L.Prentice,J.Robbins,J.E.Rossouw,G.E.Sarto,I.J.Schatz,
L.G.Snetselaar,V.J.Stevens,L.F.Tinker,M.Trevisan,M.Z.Vitolins,G.L.Anderson,
provide important information for a larger outcomes-based trial eval-
A.R.Assaf,T.Bassford,S.A.Beresford,H.R.Black,R.L.Brunner,R.G.Brzyski,
uatingdietarystrategiestodecreaseinflammationandimprovegluco-
B.Caan,R.T.Chlebowski,M.Gass,I.Granek,P.Greenland,J.Hays,D.Heber,
metabolicprofilesinpatientswithCAD. G.Heiss,S.L.Hendrix,F.A.Hubbell,K.C.Johnson,J.M.Kotchen,Low-fatdietary
patternandriskofcardiovasculardisease:theWomen'shealthinitiativerando-
mizedcontrolleddietarymodificationtrial,JAMA295(2006)655–666.
Acknowledgements [15] R.Estruch,E.Ros,J.Salas-Salvadó,M.I.Covas,D.Corella,F.Arós,E.Gómez-
Gracia,V.Ruiz-Gutiérrez,M.Fiol,J.Lapetra,R.M.Lamuela-Raventos,L.Serra-
Binita Shah was supported in part by the National Center for Majem,X.Pintó,J.Basora,M.A.Muñoz,J.V.Sorlí,J.A.Martínez,M.A.Martínez-
González,PREDIMEDStudyInvestigators.Primarypreventionofcardiovascular
AdvancingTranslationalSciences(NYUCTSAUL1TR000038)andNew diseasewithaMediterraneandiet,N.Engl.J.Med.368(2013)1279–1290.
YorkState(EmpireClinicalResearchInvestigatorProgram)in2015and [16] H.S.Dod,R.Bhardwaj,V.Sajja,G.Weidner,G.R.Hobbs,G.W.Konat,
theBiomedical Laboratory Research&Development Service oftheVA S.Manivannan,W.Gharib,B.E.Warden,N.C.Nanda,R.J.Beto,D.Ornish,
Office of Research and Development (iK2CX001074) in 2016. Dr. flA a.C m. mJa ai tn o, ryEff me ac rt ko ef rsin ot fen as ti hv ee roli sf ce ls et ry ol se isc ,h Aa mng .e Js .o Cn are dn id oo l.th 1e 0l 5ia (l 2f 0u 1n 0ct )io 3n 62a –n 3d 6o 7n
.
in-
NewmanwaspartiallyfundedbytheNationalHeart,Lung,andBlood [17] D.Ornish,L.W.Scherwitz,R.S.Doody,D.Kesten,S.M.McLanahan,S.E.Brown,
Institute (NHBLI) of the National Institute of Health (NIH, E.DePuey,R.Sonnemaker,C.Haynes,J.Lester,G.K.McAllister,R.J.Hall,
J.A.Burdine,A.M.GottoJr.,Effectsofstressmanagementtraininganddietary
K23HL125991)andtheAmericanHeartAssociationMentoredClinical changesintreatingischemicheartdisease,JAMA249(1983)54–59.
andPopulationResearchAward(15MCPRP24480132).Statisticalsup- [18] D.Ornish,S.E.Brown,L.W.Scherwitz,J.H.Billings,W.T.Armstrong,T.A.Ports,
port was provided in part by the New York University School of S.M.McLanahan,R.L.Kirkeeide,R.J.Brand,K.L.Gould,Canlifestylechangesre-
versecoronaryheartdisease?TheLifestyleHeartTrial,Lancet336(1990)129–133.
MedicineCardiovascularOutcomesGroup.
[19] L.Hansson,T.Hedner,B.Dahlöf,Prospectiverandomizedopenblindedend-point
WewouldliketoacknowledgethecontributionsofBryanVelezde (PROBE)study.Anoveldesignforinterventiontrials.ProspectiveRandomized
Villa,BS;EriniFarid;ChristineA.Berthoumieux,BA;ElissaDriggin,BS; OpenBlindedEnd-Point,BloodPress1(1992)113–119.
MelissaGoldman,MA;andTamsinShephard,BStothedatacollection [20] R.M.Ryan,J.P.Connell,Perceivedlocusofcausalityandinternalization:examining
reasonsforactingintwodomains,J.Personal.Soc.Psychol.57(1989)749–761.
andelectronicentryforthisstudy. [21] C.S.Levesque,G.C.Williams,D.Elliot,M.A.Pickering,B.Bodenhamer,P.J.Finley,
ValidatingthetheoreticalstructureoftheTreatmentSelf-RegulationQuestionnaire
AppendixA. Supplementarydata
(TSRQ)acrossthreedifferenthealthbehaviors,HealthEduc.Res.22(2007)
691–702.
[22] T.G.Pickering,J.E.Hall,L.J.Appel,B.E.Falkner,J.Graves,M.N.Hill,D.W.Jones,
Supplementarydatarelatedtothisarticlecanbefoundathttp://dx. T.Kurtz,S.G.Sheps,E.J.Roccella,Recommendationsforbloodpressuremeasure-
doi.org/10.1016/j.conctc.2017.09.003. mentinhumansandexperimentalanimals:part1:bloodpressuremeasurementin
humans:astatementforprofessionalsfromtheSubcommitteeofProfessionaland
PublicEducationoftheAmericanHeartAssociationCouncilonHighBloodPressure
References Research,Circulation111(2005)697–716.
[23] P.O.Bonetti,G.M.Pumper,S.T.Higano,D.R.HolmesJr.,J.T.Kuvin,A.Lerman,
Noninvasiveidentificationofpatientswithearlycoronaryatherosclerosisbyas-
[1] R.R.Packard,P.Libby,Inflammationinatherosclerosis:fromvascularbiologyto sessmentofdigitalreactivehyperemia,J.Am.Coll.Cardiol.44(2004)2137–2141.
biomarkerdiscoveryandriskprediction,Clin.Chem.54(2008)24–38.
[24] R.Rabin,F.deCharro,EQ-5D:ameasureofhealthstatusfromtheEuroQolGroup,
[2] M.Nidorf,P.L.Thompson,Effectofcolchicine(0.5mgtwicedaily)onhigh-sensi- Ann.Med.33(2001)337–343.
tivityC-reactiveproteinindependentofaspirinandatorvastatininparticipantswith [25] C.L.Craig,A.L.Marshall,M.Sjöström,A.E.Bauman,M.L.Booth,B.E.Ainsworth,
stablecoronaryarterydisease,Am.J.Cardiol.99(2007)805–807.
M.Pratt,U.Ekelund,A.Yngve,J.F.Sallis,P.Oja,Internationalphysicalactivity
[3] S.M.Nidorf,J.W.Eikelboom,C.A.Budgeon,etal.,Low-dosecolchicineforsec-
questionnaire:12-countryreliabilityandvalidity,Med.Sci.SportsExerc35(2003)
ondarypreventionofcardiovasculardisease,J.Am.Coll.Cardiol.61(2013) 1381–1395.
404–410.
[26] R.A.Koeth,Z.Wang,B.S.Levison,etal.,IntestinalmicrobiotametabolismofL-
[4] G.Patti,C.Massimo,V.Pasceri,D.Colonna,A.Nusca,M.Miglionico,
carnitine,anutrientinredmeat,promotesatherosclerosis,Nat.Med.19(2013)
A.D'Ambrosio,E.Covino,G.DiSciascio,Protectionfromproceduralmyocardial 576–585.
injurybyatorvastatinisassociatedwithlowerlevelsofadhesionmoleculesafter [27] P.A.Harris,R.Taylor,R.Thielke,J.Payne,N.Gonzalez,J.G.Conde,Research
percutaneouscoronaryintervention:resultsfromtheARMYDA-CAMssubstudy,J. electronicdatacapture(REDCap)-Ametadata-drivenmethodologyandworkflow
Am.Coll.Cardiol.48(2006)1560–1566.
processforprovidingtranslationalresearchinformaticssupport,J.Biomed.Inf.42
[5] V.Pasceri,G.Patti,A.Nusca,C.Pristipino,G.Richichi,G.DiSciascio,Randomized (2009)377–381.
trialofatorvastatinforreductionofmyocardialdamageduringcoronaryinter- [28] J.Jiao,J.Y.Xu,W.Zhang,S.Han,L.Q.Qin,EffectofdietaryfiberoncirculatingC-
vention:resultsfromtheARMYDAstudy,Circulation110(2004)674–678.
reactiveproteininoverweightandobeseadults:ameta-analysisofrandomized
[6] M.Kwaijtaal,R.vanDiest,F.W.Bar,A.J.vanderVen,C.A.Bruggeman,M.H.de controlledtrials,Int.J.FoodSci.Nutr.66(2015)114–119.
Baets,A.Appels,Inflammatorymarkerspredictlatecardiaceventsinparticipants
[29] B.Gopinath,A.E.Buyken,V.M.Flood,M.Empson,E.Rochtchina,P.Mitchell,
whoareexhaustedafterpercutnaeouscoronaryintervention,Atherosclerosis182 Consumptionofpolyunsaturatedfattyacids,fish,andnutsandriskofinflammatory
(2005)341–348.
diseasemortality,Am.J.Clin.Nutr.93(2011)1073–1079.
[7] A.Buffon,G.Liuzzo,L.M.Biascucci,P.Pasqualetti,V.Ramazzotti,A.G.Rebuzzi,
[30] A.Oliveira,F.Rodríguez-Artalejo,C.Lopes,Theassociationoffruits,vegetables,
F.Crea,A.Maseri,PreproceduralserumlevelsofC-reactiveproteinpredictearly
97
B.Shahetal. Contemporary Clinical Trials Communications 8 (2017) 90–98
antioxidantvitaminsandfibreintakewithhigh-sensitivityC-reactiveprotein:sex [33] M.deLorgeril,S.Renaud,N.Mamelle,P.Salen,J.L.Martin,I.Monjaud,
andbodymassindexinteractions,Eur.J.Clin.Nutr.63(2009)1345–1352. J.Guidollet,P.Touboul,J.Delaye,Mediterraneanalpha-linolenicacid-richdietin
[31] J.Corley,J.A.Kyle,J.M.Starr,G.McNeill,I.J.Deary,Dietaryfactorsandbio- secondarypreventionofcoronaryheartdisease,Lancet343(1994Jun11)
markersofsystemicinflammationinolderpeople:theLothianBirthCohort1936, 1454–1459.
Br.J.Nutr.114(2015)1088–1098. [34] S.Desroches,A.Lapointe,S.Ratte,K.Gravel,F.Legare,J.Thirsk,Interventionsto
[32] D.H.Ryan,M.A.Espeland,G.D.Foster,S.M.Haffner,V.S.Hubbard,K.C.Johnson, enhanceadherencetodietaryadviceforpreventingandmanagingchronicdiseases
S.E.Kahn,W.C.Knowler,S.Z.Yanovski,LookAHEADResearchGroup.Look inadults:astudyprotocol,BMCPublicHealth11(2011)111.
AHEAD(ActionforHealthinDiabetes):designandmethodsforaclinicaltrialof [35] S.Desroches,A.Lapointe,S.Ratte,K.Gravel,F.Legare,S.Turcotte,Interventionsto
weightlossforthepreventionofcardiovasculardiseaseintype2diabetes,Control enhanceadherencetodietaryadviceforpreventingandmanagingchronicdiseases
Clin.Trials24(2003)610–618. inadults,CochraneDatabaseSyst.Rev.(2013)CD008722.
98
